Protagonist Therapeutics announced the appointment of Asif Ali as Executive Vice President and Chief Financial Officer (CFO). In this role, Asif's responsibilities will extend across all finance-related functions within the company, including financial planning and analysis, taxation, accounting and financial reporting, finance operations, investor relations, and strategic partnership-related financings. Asif will join Protagonist in mid-April.

He comes to Protagonist from Theravance Biopharma, where he served as Chief Accounting Officer. At Theravance, Asif's scope of oversight and contributions included equity and asset-backed financings, strategic collaborations, finance operations, and international tax planning. Asif's prior work as Vice President and Controller at Depomed, Inc. included support of five product launches, four successful product acquisitions, and a significant financing from the sale of future royalties.